Macleods FDA Friday, August 15, 2014 -0.30 Negative

FDA Approves OLANZAPINE — Macleods Pharmaceuticals Limited

Macleods Pharmaceuticals has received approval from the U.S. Food and Drug Administration for its abbreviated new drug application, #ANDA202862, to manufacture and market olanzapine oral tablets. This move is expected to introduce a generic competitor into the antipsychotic market, potentially driving down prices and increasing competition for the established brand.

View original filing at SEC.gov →
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.

Get real-time financial news in your trading bot or app

START FREE — 10,000 calls/day, no key needed